Oppenheimer & Co. Inc. raised its stake in Mead Johnson Nutrition Co. (NYSE:MJN) by 11.3% during the second quarter, Holdings Channel reports. The firm owned 4,617 shares of the company’s stock after buying an additional 467 shares during the period. Oppenheimer & Co. Inc.’s holdings in Mead Johnson Nutrition were worth $419,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of MJN. M&T Bank Corp boosted its stake in shares of Mead Johnson Nutrition by 30.5% in the first quarter. M&T Bank Corp now owns 20,609 shares of the company’s stock worth $1,751,000 after buying an additional 4,818 shares during the period. Nomura Asset Management Co. Ltd. boosted its stake in shares of Mead Johnson Nutrition by 0.4% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 95,276 shares of the company’s stock worth $7,522,000 after buying an additional 400 shares during the period. Bessemer Group Inc. boosted its stake in shares of Mead Johnson Nutrition by 634.5% in the first quarter. Bessemer Group Inc. now owns 2,894 shares of the company’s stock worth $246,000 after buying an additional 2,500 shares during the period. Dynamic Advisors Solutions LLC boosted its stake in shares of Mead Johnson Nutrition by 88.5% in the first quarter. Dynamic Advisors Solutions LLC now owns 15,578 shares of the company’s stock worth $1,324,000 after buying an additional 7,313 shares during the period. Finally, Sensato Investors LLC bought a new stake in shares of Mead Johnson Nutrition during the first quarter worth $13,841,000. Institutional investors and hedge funds own 97.11% of the company’s stock.

Mead Johnson Nutrition Co. (NYSE:MJN) opened at 76.75 on Friday. The firm has a market capitalization of $14.17 billion, a price-to-earnings ratio of 28.88 and a beta of 1.17. Mead Johnson Nutrition Co. has a 12 month low of $65.53 and a 12 month high of $94.40. The firm’s 50-day moving average is $85.70 and its 200 day moving average is $84.70.

Mead Johnson Nutrition (NYSE:MJN) last posted its quarterly earnings results on Thursday, July 28th. The company reported $0.88 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.78 by $0.10. Mead Johnson Nutrition had a net margin of 13.28% and a negative return on equity of 194.30%. The business earned $941.50 million during the quarter, compared to analyst estimates of $967.25 million. During the same period in the previous year, the business posted $0.76 EPS. The company’s quarterly revenue was down 8.8% on a year-over-year basis. Equities analysts predict that Mead Johnson Nutrition Co. will post $3.49 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 3rd. Stockholders of record on Monday, September 19th will be issued a $0.4125 dividend. This represents a $1.65 annualized dividend and a dividend yield of 2.15%. The ex-dividend date is Thursday, September 15th. Mead Johnson Nutrition’s dividend payout ratio (DPR) is presently 62.03%.

A number of equities research analysts recently weighed in on the stock. Deutsche Bank AG set a $88.00 price target on shares of Mead Johnson Nutrition and gave the company a “hold” rating in a research report on Sunday, July 24th. Susquehanna reissued a “hold” rating on shares of Mead Johnson Nutrition in a research report on Sunday, July 17th. Credit Agricole SA raised shares of Mead Johnson Nutrition from an “underperform” rating to an “outperform” rating and set a $96.00 price target for the company in a research report on Wednesday, August 3rd. Goldman Sachs Group Inc. reaffirmed a “neutral” rating and issued a $96.00 target price (up from $91.00) on shares of Mead Johnson Nutrition in a report on Friday, July 15th. Finally, Bank of America Corp. raised shares of Mead Johnson Nutrition from an “underperform” rating to a “neutral” rating and set a $93.00 target price for the company in a report on Wednesday, July 13th. One analyst has rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $95.75.

In other news, Director Kimberly A. Casiano sold 710 shares of Mead Johnson Nutrition stock in a transaction dated Monday, August 15th. The shares were sold at an average price of $89.75, for a total value of $63,722.50. Following the completion of the transaction, the director now directly owns 7,110 shares of the company’s stock, valued at approximately $638,122.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Graciela Monteagudo sold 45,873 shares of Mead Johnson Nutrition stock in a transaction dated Friday, August 5th. The shares were sold at an average price of $87.64, for a total transaction of $4,020,309.72. Following the completion of the transaction, the senior vice president now directly owns 13,800 shares of the company’s stock, valued at $1,209,432. The disclosure for this sale can be found here. 0.50% of the stock is currently owned by insiders.

About Mead Johnson Nutrition

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

5 Day Chart for NYSE:MJN

Want to see what other hedge funds are holding MJN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mead Johnson Nutrition Co. (NYSE:MJN).

Receive News & Ratings for Mead Johnson Nutrition Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.